R&D The value of unstructured data for drug companies Advancements in medical AI now allow pharmaceutical companies to leverage unstructured clinical data at scale.
Views & Analysis Solving the Big Data problem in pharma innovation The effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry. What can be done to overcome this issue?
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
